Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients

BACKGROUND: Atrial fibrillation (AF) is the most frequent tachyarrhythmia in patients with a permanent pacemaker. Angiotensin II receptor antagonists have a protective effect against the occurrence of AF in patients with heart diseases. This study aimed to assess the effectiveness of olmesartan in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hang, Pan, Chang, Zhang, Juan, Zhu, Lin-Lin, Huang, Kai, Zhong, Yun, Hu, Zuo-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022331/
https://www.ncbi.nlm.nih.gov/pubmed/27625082
http://dx.doi.org/10.4103/0366-6999.189924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022331/
https://www.ncbi.nlm.nih.gov/pubmed/27625082
http://dx.doi.org/10.4103/0366-6999.189924

Ejemplares similares